All News about Cellectis S.A. ADR![]() From Cellectis Inc.
Via GlobeNewswire
![]() ![]() Via Benzinga
![]()
Cellectis Touts Positive Preliminary Data From Two Leukemia Trials
December 13, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]()
Cellectis to Host a Live Webcast and Provide a Company Update on December 13, 2022
December 01, 2022
From Cellectis Inc.
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]()
Cellectis to Report Third Quarter 2022 Financial Results
October 27, 2022
From Cellectis Inc.
Via GlobeNewswire
![]() ![]() Via Benzinga
![]() ![]() ![]()
Cellectis Appoints Mark Frattini, M.D., Ph.D. as Chief Medical Officer
September 28, 2022
From Cellectis Inc.
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]()
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 01, 2022
Via Benzinga
![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Cellectis S.A. ADR (NQ: CLLS )All News about Cellectis S.A. ADR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|